Arcutis Biotherapeutics Inc
NASDAQ:ARQT

Watchlist Manager
Arcutis Biotherapeutics Inc Logo
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Watchlist
Price: 14.62 USD 0.41% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Arcutis Biotherapeutics Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-8.9
Current
-3.7
Median
6.1
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-8.9
=
Enterprise Value
1.5B USD
/
Operating Cash Flow
-167.7m USD
All Countries
Close
 
US
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Average EV/OCF: 22.1
Negative Multiple: -8.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -242 833.4
US
Abbvie Inc
NYSE:ABBV
22.5
US
Amgen Inc
NASDAQ:AMGN
25.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -463.7
AU
CSL Ltd
ASX:CSL
34.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -72.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -133.1

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A